Testing effectiveness (Phase 2)Looking for participantsNCT06124963
What this trial is testing
WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations
Who this might be right for
Gastric Type Adenocarcinoma (GAS) With STK11 Mutation
Shanghai Jiatan Pharmatech Co., Ltd 20